Skip to content
Reckitt Benckiser
Search
Join RB’s networks
Facebook
Twitter
RB Early Life Blog
LinkedIn
YouTube
Google Plus
Share
Sitemap
HTML version
Text only version
RB worldwide
Global locations
Executive Committee
The Board
RB history
Contact us
Careers & students
Apply now
Jobs for professionals
Graduates & interns
What it's like at RB
Just for fun
Innovators
Products
People
Awards
Our brands
Powerbrands on the shelf
Products around the home
Commercial break
Search RB Brands A-Z
Category performance
Healthcare Brands Employee Reporting
Suboxone, Subutex & Temgesic adverse events reporting
Our responsibility
Environment
Carbon20
Community
A Million Brighter Futures
Reporting an issue
Our policies & reports
Investors & media
Announcements
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Contact us
Home
>
Investors & media
>
Announcements
>
2010
>
Reckitt Benckiser GP Directorate Change
Investors & media
Announcements
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Contact us
Announcements
RB Press Release - 22/10/10
Colin Day, CFO, to leave RB
Reckitt Benckiser (RB) announces that Colin Day, chief financial officer and executive member of the Board will leave the company. His successor will be announced in the next few months.
Effective succession management is an important business principle in RB. Colin wants to focus increasingly on his portfolio of non-executive positions and other career interests, and the Board has decided that now is a good time to appoint a successor keen to focus on leading the company’s finance function in support of the next stage of RB’s growth.
Bart Becht, CEO, Adrian Bellamy, Chairman, and the rest of the Board want to thank Colin for his 10 years as chief financial officer (CFO). During his tenure he has made a significant contribution to the performance of the business. Our appreciation is in particular for ensuring strong financial management and control, overseeing excellent cash generation and working with the leadership team on a number of key strategic acquisitions. He hands across a baton of a company in a strong financial position for someone else to now take forward.
To ensure a smooth transition and an effective handover Colin will remain with the business until end of March 2011.
ENDS
Enquiries:
Investor and analyst enquiries:
Jo Speed, RB, Investor Relations Director, +44 (0) 1753 217 800
Media enquiries:
Andraea Dawson-Shepherd, RB, +44 (0) 1753 217 800
David Litterick/Teresa Bianchi, Brunswick +44 (0) 20 7404 5959
Reckitt_Benckiser_CFO_press_release.pdf
Colin Day, CFO
...read more
Print this page